• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NSUN6 介导的 NDRG1 mRNA 5-甲基胞嘧啶修饰促进宫颈癌的放射抵抗。

NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer.

机构信息

Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.

出版信息

Mol Cancer. 2024 Jul 5;23(1):139. doi: 10.1186/s12943-024-02055-2.

DOI:10.1186/s12943-024-02055-2
PMID:38970106
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11225205/
Abstract

BACKGROUND

Radioresistance is the leading cause of death in advanced cervical cancer (CC). Dysregulation of RNA modification has recently emerged as a regulatory mechanism in radiation and drug resistance. We aimed to explore the biological function and clinical significance of 5-methylcytosine (mC) in cervical cancer radiosensitivity.

METHODS

The abundance of RNA modification in radiotherapy-resistant and sensitive CC specimens was quantified by liquid chromatography-tandem mass spectrometry. The essential RNA modification-related genes involved in CC radiosensitivity were screened via RNA sequencing. The effect of NSUN6 on radiosensitivity was verified in CC cell lines, cell-derived xenograft (CDX), and 3D bioprinted patient-derived organoid (PDO). The mechanisms of NSUN6 in regulating CC radiosensitivity were investigated by integrative mC sequencing, mRNA sequencing, and RNA immunoprecipitation.

RESULTS

We found a higher abundance of mC modification in resistant CC samples, and NSUN6 was the essential mC-regulating gene concerning radiosensitivity. NSUN6 overexpression was clinically correlated with radioresistance and poor prognosis in cervical cancer. Functionally, higher NSUN6 expression was associated with radioresistance in the 3D PDO model of cervical cancer. Moreover, silencing NSUN6 increased CC radiosensitivity in vivo and in vitro. Mechanistically, NDRG1 was one of the downstream target genes of NSUN6 identified by integrated mC-seq, mRNA-seq, and functional validation. NSUN6 promoted the mC modification of NDRG1 mRNA, and the mC reader ALYREF bound explicitly to the mC-labeled NDRG1 mRNA and enhanced NDRG1 mRNA stability. NDRG1 overexpression promoted homologous recombination-mediated DNA repair, which in turn led to radioresistance in cervical cancer.

CONCLUSIONS

Aberrant mC hypermethylation and NSUN6 overexpression drive resistance to radiotherapy in cervical cancer. Elevated NSUN6 expression promotes radioresistance in cervical cancer by activating the NSUN6/ALYREF-mC-NDRG1 pathway. The low expression of NSUN6 in cervical cancer indicates sensitivity to radiotherapy and a better prognosis.

摘要

背景

放射抵抗是晚期宫颈癌(CC)死亡的主要原因。RNA 修饰的失调最近成为放射和耐药性的调节机制。我们旨在探索 5-甲基胞嘧啶(mC)在宫颈癌放射敏感性中的生物学功能和临床意义。

方法

通过液相色谱-串联质谱法定量测定放射抵抗和敏感 CC 标本中 RNA 修饰的丰度。通过 RNA 测序筛选涉及 CC 放射敏感性的关键 RNA 修饰相关基因。在 CC 细胞系、细胞衍生异种移植(CDX)和 3D 生物打印患者来源的类器官(PDO)中验证 NSUN6 对放射敏感性的影响。通过整合 mC 测序、mRNA 测序和 RNA 免疫沉淀研究 NSUN6 调节 CC 放射敏感性的机制。

结果

我们发现抗性 CC 样本中 mC 修饰的丰度更高,而 NSUN6 是涉及放射敏感性的关键 mC 调节基因。NSUN6 过表达与宫颈癌的放射抵抗和不良预后相关。功能上,更高的 NSUN6 表达与宫颈癌 3D PDO 模型中的放射抵抗有关。此外,沉默 NSUN6 可增加体内和体外 CC 的放射敏感性。从机制上讲,NDRG1 是通过整合 mC-seq、mRNA-seq 和功能验证鉴定的 NSUN6 的下游靶基因之一。NSUN6 促进 NDRG1 mRNA 的 mC 修饰,mC 阅读器 ALYREF 特异性结合 mC 标记的 NDRG1 mRNA 并增强 NDRG1 mRNA 的稳定性。NDRG1 过表达促进同源重组介导的 DNA 修复,从而导致宫颈癌的放射抵抗。

结论

异常的 mC 高甲基化和 NSUN6 过表达驱动宫颈癌对放疗的抵抗。升高的 NSUN6 表达通过激活 NSUN6/ALYREF-mC-NDRG1 通路促进宫颈癌的放射抵抗。宫颈癌中 NSUN6 的低表达表明对放疗敏感且预后更好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/11225205/c1be03190262/12943_2024_2055_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/11225205/7348d2f28352/12943_2024_2055_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/11225205/6ca455bbae88/12943_2024_2055_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/11225205/b908dddc55dc/12943_2024_2055_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/11225205/3be8fcb99c61/12943_2024_2055_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/11225205/b04ac8717196/12943_2024_2055_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/11225205/c1be03190262/12943_2024_2055_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/11225205/7348d2f28352/12943_2024_2055_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/11225205/6ca455bbae88/12943_2024_2055_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/11225205/b908dddc55dc/12943_2024_2055_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/11225205/3be8fcb99c61/12943_2024_2055_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/11225205/b04ac8717196/12943_2024_2055_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f083/11225205/c1be03190262/12943_2024_2055_Fig6_HTML.jpg

相似文献

1
NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer.NSUN6 介导的 NDRG1 mRNA 5-甲基胞嘧啶修饰促进宫颈癌的放射抵抗。
Mol Cancer. 2024 Jul 5;23(1):139. doi: 10.1186/s12943-024-02055-2.
2
NSUN6 mediates 5-methylcytosine modification of METTL3 and promotes colon adenocarcinoma progression.NSUN6 介导 METTL3 的 5-甲基胞嘧啶修饰并促进结肠腺癌进展。
J Biochem Mol Toxicol. 2024 Jun;38(6):e23749. doi: 10.1002/jbt.23749.
3
Silencing of hsa_circ_0009035 Suppresses Cervical Cancer Progression and Enhances Radiosensitivity through MicroRNA 889-3p-Dependent Regulation of HOXB7.hsa_circ_0009035 的沉默通过 microRNA 889-3p 依赖调控 HOXB7 抑制宫颈癌进展并增强放射敏感性。
Mol Cell Biol. 2021 May 21;41(6):e0063120. doi: 10.1128/MCB.00631-20.
4
METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer.METTL14 通过 m6A 甲基化降低 FTH1 mRNA 稳定性以促进索拉非尼诱导的宫颈癌铁死亡。
Cancer Biol Ther. 2024 Dec 31;25(1):2349429. doi: 10.1080/15384047.2024.2349429. Epub 2024 May 13.
5
NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization.NSUN4 介导的 RNA 5-甲基胞嘧啶通过提高 CDC42 mRNA 的稳定性促进胶质瘤的恶性进展。
Cancer Lett. 2024 Aug 10;597:217059. doi: 10.1016/j.canlet.2024.217059. Epub 2024 Jun 13.
6
SETD3 reduces KLC4 expression to improve the sensitization of cervical cancer cell to radiotherapy.SETD3 通过降低 KLC4 的表达来提高宫颈癌细胞对放疗的敏感性。
Biochem Biophys Res Commun. 2019 Aug 27;516(3):619-625. doi: 10.1016/j.bbrc.2019.06.058. Epub 2019 Jun 22.
7
Targeting NEK2 impairs oncogenesis and radioresistance via inhibiting the Wnt1/β-catenin signaling pathway in cervical cancer.靶向 NEK2 通过抑制宫颈癌中的 Wnt1/β-catenin 信号通路来抑制肿瘤发生和放射抵抗。
J Exp Clin Cancer Res. 2020 Sep 10;39(1):183. doi: 10.1186/s13046-020-01659-y.
8
Aldolase A promotes cervical cancer cell radioresistance by regulating the glycolysis and DNA damage after irradiation.醛缩酶 A 通过调节照射后糖酵解和 DNA 损伤促进宫颈癌放疗抵抗。
Cancer Biol Ther. 2023 Dec 31;24(1):2287128. doi: 10.1080/15384047.2023.2287128. Epub 2023 Nov 27.
9
BRD4 inhibition sensitizes cervical cancer to radiotherapy by attenuating DNA repair.BRD4 抑制通过减弱 DNA 修复使宫颈癌对放射治疗敏感。
Oncogene. 2021 Apr;40(15):2711-2724. doi: 10.1038/s41388-021-01735-3. Epub 2021 Mar 12.
10
RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer.RhoC 通过 ROCK2 与宫颈癌 DNA 修复机制的串扰调节放射抵抗性。
J Exp Clin Cancer Res. 2019 Sep 5;38(1):392. doi: 10.1186/s13046-019-1385-7.

引用本文的文献

1
Epitranscriptomic mechanisms and implications of RNA mC modification in cancer.癌症中RNA mC修饰的表观转录组学机制及其影响
Theranostics. 2025 Jul 25;15(16):8404-8428. doi: 10.7150/thno.112332. eCollection 2025.
2
m5C RNA modification in colorectal cancer: mechanisms and therapeutic targets.结直肠癌中的m5C RNA修饰:机制与治疗靶点
J Transl Med. 2025 Aug 21;23(1):948. doi: 10.1186/s12967-025-06985-3.
3
Advances in research on RNA methylation and cancer radiotherapy resistance.RNA甲基化与癌症放疗抗性的研究进展

本文引用的文献

1
TRAIL-driven targeting and reversing cervical cancer radioresistance by seleno-nanotherapeutics through regulating cell metabolism.硒纳米治疗通过调节细胞代谢来实现 TRAIL 驱动的靶向治疗并逆转宫颈癌放射抵抗。
Drug Resist Updat. 2024 Jan;72:101033. doi: 10.1016/j.drup.2023.101033. Epub 2023 Dec 9.
2
CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method.CHARIOT 研究:贝佐司他联合放化疗治疗食管及其他实体瘤的 I 期研究,采用时间事件连续评估方法。
Br J Cancer. 2024 Feb;130(3):467-475. doi: 10.1038/s41416-023-02542-1. Epub 2023 Dec 21.
3
Front Oncol. 2025 Jul 31;15:1596541. doi: 10.3389/fonc.2025.1596541. eCollection 2025.
4
Quantifying the mRNA epitranscriptome reveals epitranscriptome signatures and roles in cancer.对信使核糖核酸表观转录组进行定量分析揭示了表观转录组特征及其在癌症中的作用。
Cell Mol Life Sci. 2025 Jul 28;82(1):290. doi: 10.1007/s00018-025-05805-7.
5
Identification and validation of a prognostic signature of mC-related genes for esophageal cancer.食管癌中与甲基化胞嘧啶相关基因的预后特征的鉴定与验证
J Thorac Dis. 2025 Jun 30;17(6):4117-4135. doi: 10.21037/jtd-2025-768. Epub 2025 Jun 26.
6
MARCH8/NSUN6/ROS-mediated DNA damage positive feedback loop regulates cisplatin resistance in osteosarcoma.MARCH8/NSUN6/活性氧介导的DNA损伤正反馈回路调节骨肉瘤中的顺铂耐药性。
Cell Death Differ. 2025 Jul 19. doi: 10.1038/s41418-025-01544-1.
7
Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.将表观遗传调节因子作为克服癌症治疗耐药性的一条有前景的途径。
Signal Transduct Target Ther. 2025 Jul 18;10(1):219. doi: 10.1038/s41392-025-02266-z.
8
METTL3 mediates m6A methylation modification of ULBP2 and affects the progression of cervical cancer.METTL3介导ULBP2的m6A甲基化修饰并影响宫颈癌的进展。
Hereditas. 2025 Jul 10;162(1):123. doi: 10.1186/s41065-025-00483-8.
9
NSUN6 Maintains BMPER Stability in an m5C-Dependent Manner to Suppress Cell Proliferation and Migration in Hepatocellular Carcinoma.NSUN6以依赖于m5C的方式维持BMPER稳定性,从而抑制肝癌细胞的增殖和迁移。
Biol Cell. 2025 Jul;117(7):e70023. doi: 10.1111/boc.70023.
10
ECM characterization and 3D bioprinted models of NSCLC for investigating stiffness-dependent tumor behavior and drug response.用于研究硬度依赖性肿瘤行为和药物反应的非小细胞肺癌的细胞外基质表征及3D生物打印模型
Mater Today Bio. 2025 Apr 30;32:101823. doi: 10.1016/j.mtbio.2025.101823. eCollection 2025 Jun.
Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via mC modification of SLC7A11 mRNA.
表观遗传上调的 NSUN2 通过 SLC7A11 mRNA 的 mC 修饰赋予子宫内膜癌对铁死亡的抗性。
Redox Biol. 2024 Feb;69:102975. doi: 10.1016/j.redox.2023.102975. Epub 2023 Nov 29.
4
NSUN6 Regulates NM23-H1 Expression in an m5C Manner to Affect Epithelial-Mesenchymal Transition in Lung Cancer.NSUN6 通过 m5C 方式调控 NM23-H1 的表达来影响肺癌中的上皮间质转化。
Med Princ Pract. 2024;33(1):56-65. doi: 10.1159/000535479. Epub 2023 Nov 29.
5
The m C methyltransferase NSUN2 promotes codon-dependent oncogenic translation by stabilising tRNA in anaplastic thyroid cancer.m C 甲基转移酶 NSUN2 通过稳定甲状腺癌中的 tRNA 促进依赖于密码子的致癌翻译。
Clin Transl Med. 2023 Nov;13(11):e1466. doi: 10.1002/ctm2.1466.
6
Comparative analysis between 2D and 3D colorectal cancer culture models for insights into cellular morphological and transcriptomic variations.二维和三维结直肠癌培养模型的比较分析,深入了解细胞形态和转录组学变化。
Sci Rep. 2023 Oct 26;13(1):18380. doi: 10.1038/s41598-023-45144-w.
7
CDK13 promotes lipid deposition and prostate cancer progression by stimulating NSUN5-mediated m5C modification of ACC1 mRNA.CDK13 通过促进 NSUN5 介导的 ACC1 mRNA 的 m5C 修饰促进脂质沉积和前列腺癌进展。
Cell Death Differ. 2023 Dec;30(12):2462-2476. doi: 10.1038/s41418-023-01223-z. Epub 2023 Oct 16.
8
Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling.TP53 的表观遗传调控参与前列腺癌的放射抵抗和 DNA 损伤反应信号转导。
Signal Transduct Target Ther. 2023 Oct 16;8(1):395. doi: 10.1038/s41392-023-01639-6.
9
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy.胚系变异 GFI1-36N 影响 DNA 修复,并使 AML 细胞对 DNA 损伤和修复治疗敏感。
Blood. 2023 Dec 21;142(25):2175-2191. doi: 10.1182/blood.2022015752.
10
NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistance.NSUN2 是一种葡萄糖传感器,可抑制 cGAS/STING 以维持肿瘤发生和免疫治疗抵抗。
Cell Metab. 2023 Oct 3;35(10):1782-1798.e8. doi: 10.1016/j.cmet.2023.07.009. Epub 2023 Aug 15.